NewGenIvf: Purchased 13,000 SOL and approved a $2 million stock buyback plan
ChainCatcher reported that Nasdaq-listed Solana treasury company NewGenIvf disclosed in its latest financial report that the company has purchased 13,000.23 SOL and participated in a $100 million gold-backed asset tokenization project.
The financial report shows that NewGenIvf achieved a net profit of $17.5 million in the third quarter. The company's board of directors also approved a 24-month, $2 million stock repurchase program.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Novo Nordisk is open to upgrading its New York listing status.
Novo Nordisk considers upgrading its New York listing to boost its U.S. profile
Crypto prices
More
